AZD-8055 Completed Phase 1 Trials for Malignancies / Tumors, Solid / Advanced Solid Malignancies Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00973076Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055
NCT00731263A Study of Tor Kinase Inhibitor in Advanced Tumors